View full meeting coverage »

Eyetube Meeting Coverage:

2018 American Society of Retina Specialists Annual Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Key Points From the Phase 3 PANORAMA Study

  Channels: Retina | Posted 7/20/2018

In this video, Charles C. Wykoff, MD, PhD, FACS, shares highlights from his ASRS talk on intravitreal aflibercept (Eylea, Regeneron) for the treatment of patients with moderately severe to severe nonproliferative diabetic retinopathy.

Diabetic Retinopathy • Eylea • Intravitreal Injection • Regeneron Pharmaceuticals


5 / 17 Series: 2018 American Society of Retina Specialists Annual Meeting